Literature DB >> 27071309

Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.

Roberta Fusco1, Mario Sansone2, Mario Petrillo3, Sergio Venanzio Setola3, Vincenza Granata3, Gerardo Botti4, Sisto Perdonà5, Valentina Borzillo3, Paolo Muto3, Antonella Petrillo3.   

Abstract

INTRODUCTION: Early promising data suggest that combined use of both morphological and functional MRI (multi-parametric MR, mpMRI) including MRSI, DWI and DCE may be of additional value for prostate cancer localization and its local staging. The objective of this paper is to evaluate the diagnostic performance of mpMRI in the detection of prostate cancer.
METHODS: Thirty-one consecutive male patients were screened to be enrolled in a single center prospective observational study. All eligible patients underwent multi-parametric MRI and TRUS (Trans Rectal Ultra Sound) guided prostate biopsies. A register, approved by the Institutional Ethics Committee, included patients enrolled in this study. All patients who decided to undergo the MRI examination signed an explicit informed consensus. MRI data were aligned on a common spatial grid and several functional parameters (perfusion, diffusion and metabolic parameters) were computed. Statistical analysis was conducted in order to compare mpMRI with biopsy-based analysis.
RESULTS: Statistically significant differences between median values in high Gleason score (≥5) and low Gleason score (<5) to Wilcox on rank sum test were obtained for MRSI parameters and for plasma fraction (Tofts model) of DCE-MRI. The area under curve obtained with ROC analysis showed that the best-performing single-parameter was vp (plasma fraction of Tofts model), while the best parameters combination to discriminate the area with high Gleason score were (Cho+Cr)/Cit and Cho+Cr. Linear Discrimination Analysis showed that the best results were obtained considering the linear combination of all MRSI parameters and the linear combination of all features (perfusion, diffusion and metabolic parameters).
CONCLUSIONS: In conclusion, our findings showed that by combining morphological MRI, DWI, DCE-MRI and MRSI, an increase in sensitivity and specificity correlated to biopsy Gleason grade could be obtained. Furthermore, morphological and functional MRI could have a diagnostic role in patients with prostate cancer, identifying those patients who will have a negative work-up and those patients at high risk for a high Gleason score cancer of the prostate.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer detection; Magnetic resonance imaging; Multiparametric analysis; Prostate cancer

Mesh:

Substances:

Year:  2016        PMID: 27071309     DOI: 10.1016/j.mri.2016.04.001

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  11 in total

1.  Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.

Authors:  Grégory Kuchcinski; Emilie Le Rhun; Alexis B Cortot; Elodie Drumez; Romain Duhal; Maxime Lalisse; Julien Dumont; Renaud Lopes; Jean-Pierre Pruvo; Xavier Leclerc; Christine Delmaire
Journal:  Eur Radiol       Date:  2017-02-16       Impact factor: 5.315

2.  Peribiliary liver metastases MR findings.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Antonio Avallone; Maddalena Leongito; Francesco Izzo; Antonella Petrillo
Journal:  Med Oncol       Date:  2017-06-01       Impact factor: 3.064

3.  Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.

Authors:  Mehdi Taghipour; Alireza Ziaei; Francesco Alessandrino; Elmira Hassanzadeh; Mukesh Harisinghani; Mark Vangel; Clare M Tempany; Fiona M Fennessy
Journal:  Abdom Radiol (NY)       Date:  2019-04

Review 4.  A systematic review on multiparametric MR imaging in prostate cancer detection.

Authors:  Roberta Fusco; Mario Sansone; Vincenza Granata; Sergio Venanzio Setola; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2017-10-30       Impact factor: 2.965

5.  Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2.

Authors:  Zhaoyan Feng; Xiangde Min; Daniel J A Margolis; Caohui Duan; Yuping Chen; Vivek Kumar Sah; Nabin Chaudhary; Basen Li; Zan Ke; Peipei Zhang; Liang Wang
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

6.  Quantitative parameters in dynamic contrast-enhanced magnetic resonance imaging for the detection and characterization of prostate cancer.

Authors:  Cheng Wei; Bowen Jin; Magdalena Szewczyk-Bieda; Stephen Gandy; Stephen Lang; Yilong Zhang; Zhihong Huang; Ghulam Nabi
Journal:  Oncotarget       Date:  2018-03-23

7.  Multiparametric MRI reporting using Prostate Imaging Reporting and Data System version 2.0 (PI-RADSv2) retains clinical efficacy in a predominantly post-biopsy patient population.

Authors:  Edwin Jonathan Aslim; Yan Mee Law; Puay Hoon Tan; John Carson Allen; Lionel Tim-Ee Cheng; Viswanath Anand Chidambaram; Li Yan Khor; Benjamin Yongcheng Tan; Ernest Wencong Eu; Christopher Wai Sam Cheng; John Shyi Peng Yuen; Henry Sun Sien Ho; Lui Shiong Lee
Journal:  Asian J Urol       Date:  2018-06-01

8.  Histogram analysis of prostate cancer on dynamic contrast-enhanced magnetic resonance imaging: A preliminary study emphasizing on zonal difference.

Authors:  Chih-Ching Lai; Pin-Hsun Huang; Fu-Nien Wang; Shu-Huei Shen; Hsin-Kai Wang; Hsian-Tzu Liu; Hsiao-Jen Chung; Tzu-Ping Lin; Yen-Hwa Chang; Chin-Chen Pan; Shin-Lei Peng
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

9.  Radiological assessment of secondary biliary tree lesions: an update.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venanzio Setola; Antonio Avallone; Raffaele Palaia; Roberto Grassi; Francesco Izzo; Antonella Petrillo
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 10.  Prostate imaging features that indicate benign or malignant pathology on biopsy.

Authors:  Catherine Elizabeth Lovegrove; Mudit Matanhelia; Jagpal Randeva; David Eldred-Evans; Henry Tam; Saiful Miah; Mathias Winkler; Hashim U Ahmed; Taimur T Shah
Journal:  Transl Androl Urol       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.